HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 98 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -76.2% | 426 | -62.0% | 0.00% | -20.0% |
| Q1 2022 | $21,000 | -43.2% | 1,121 | +6.7% | 0.01% | -37.5% |
| Q4 2021 | $37,000 | 0.0% | 1,051 | +3.3% | 0.01% | 0.0% |
| Q3 2021 | $37,000 | +8.8% | 1,017 | +19.1% | 0.01% | 0.0% |
| Q2 2021 | $34,000 | +61.9% | 854 | +15.7% | 0.01% | +60.0% |
| Q1 2021 | $21,000 | -12.5% | 738 | -1.3% | 0.01% | +25.0% |
| Q4 2020 | $24,000 | 0.0% | 748 | -0.7% | 0.00% | -20.0% |
| Q3 2020 | $24,000 | +26.3% | 753 | +7.4% | 0.01% | +25.0% |
| Q2 2020 | $19,000 | +46.2% | 701 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $13,000 | 0.0% | 701 | +30.3% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | 0.0% | 538 | -22.9% | 0.00% | +50.0% |
| Q3 2019 | $13,000 | -40.9% | 698 | -2.5% | 0.00% | -50.0% |
| Q1 2019 | $22,000 | +37.5% | 716 | +5.1% | 0.00% | +33.3% |
| Q4 2018 | $16,000 | – | 681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
| Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
| Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
| AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
| Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
| M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
| Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
| Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
| Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |